Microsoft Corporation (MSFT): Higher Creditworthiness Than Apple Inc. (AAPL)?

Page 1 of 2

With nearly $145 billion in cash on the books, Apple Inc. (NASDAQ:AAPL) shouldn’t have problems paying bills any time soon. That’s particularly important considering the Mac maker’s recent announcement to tap the debt markets in order to fund its ambitious capital return program while leaving foreign cash untouched.

Any company seeking to raise debt capital will inevitably turn to the three major credit rating agencies for their respective seals of approval. S&P and Moody’s Corporation (NYSE:MCO) have assigned ratings, while Fitch has yet to publicly release a finalized rating. Here are the two ratings that Apple has officially earned thus far.

Rating Agency Apple Credit Rating Outlook
S&P AA+ Stable
Moody’s Aa1 Stable

Sources: S&P and Moody’s.

These are both below the credit ratings that longtime rival Microsoft Corporation (NASDAQ:MSFT) has fetched.

Rating Agency Microsoft Credit Rating Outlook
S&P AAA Stable
Moody’s Aaa Stable

Sources: S&P and Moody’s.

Microsoft earns the highest rankings from both, while Apple gets the second-best ratings. This is despite the fact that Apple has far more cash and Microsoft’s core PC business is under fire. Both companies have the majority of their cash positions locked away abroad.

Source: SEC filings. Cash and investments as of the end of March.

Microsoft Corporation (MSFT)It’s also worth pointing out that Microsoft Corporation (NASDAQ:MSFT)’s net cash position is lower because it already has $14.2 billion in long-term debt, of which $2.2 billion is current. As it turns out, both Microsoft and Apple Inc. (NASDAQ:AAPL) have recently filed prospectuses for upcoming debt offerings, which include each company’s calculations of certain credit-related metrics.

For example, the ratio of earnings to fixed charges helps credit investors assess how well profitability can cover fixed costs like interest expenses. Apple’s is soaring while Microsoft’s is dropping:

Source: SEC filings. Fiscal years ending June (Microsoft) and September (Apple) shown.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!